Chromosome alterations in breast carcinomas: Frequent involvement of DNA losses including chromosomes 4q and 21q

British Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 806-811

  Schwendel, A ^a   Richard, F ^a   Langreck, H ^a   Kaufmann, O ^a   Lage, H ^a   Winzer, K J ^a   Petersen, I ^a   Dietel, M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Breast cancer; Comparative genomic hybridization; Tumour genetics

Indexed keywords

ARTICLE; BREAST CARCINOMA; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 16P; CHROMOSOME 19; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 21Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME DISORDER; CHROMOSOME LOSS; CHROMOSOME MAP; CLINICAL ARTICLE; DNA HYBRIDIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; X CHROMOSOME;

EID: 0031714495     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.583     Document Type: Article

References (57)

1. Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM and Borresen AL (1992) Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosom Cancer 4: 113-121
2. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and Meltzer PS (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 968-968
3. Bjorkqvist AM, Tammilehto L, Anttila S, Mattson K and Knuutila S (1997) Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer 75(4): 523-527
4. Bland KI, Konstadoulakis MM, Vezeridis MP and Wanebo HJ (1995) Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg 221(6): 706-718; discussion 718-720
5. Bloom HJG and Richardson WW (1957) Histologic grading and prognosis in breast cancer. Br J Cancer 11: 359-377
6. Bockmühl U, Schwendel A, Dietel M and Petersen I (1996) Distinct pattern of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res 56: 5325-5329
7. Brison O (1993) Gene amplification and tumour progression. Biochim Biophys Acta 1155: 25-41
8. Clark GM and McGuire WL (1991) Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res 51(3): 944-948
9. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC and Jenkins RB (1193) Human epithelial ovarian cancer allelotype. Cancer Res 53(suppl. 10): 2393-2398
10. Courjal F and Theillet C (1997) Comparative genomic hybridization analysis of breast tumours with predetermined profiles of DNA amplification. Cancer Res 57: 4368-4377
11. Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R and Theillet C (1996) Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69: 247-253
12. Cox LA, Chen G, and Lee EYHP (1994) Tumour suppressor genes and their roles in breast cancer. Breast Cancer Res Treat 32: 19-38
13. Cunningham JM, Ingle JN, Jung SH, Cha SS, Wold LE, Farr G, Witzig TE, Krook JE, Wieand HS and Kovach JS (1994) p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis. J Natl Cancer Inst 86: 1871-1873
14. Devilee P, van Vliet M, van Sloun P, Kuipers Dijkshorn N, Hermans J, Pearsons PL and Cornelisse CJ (1991) Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6: 1705-1711
15. Ecles RA, Stratton MR, Goldgar DE and Easton DF (1994) The genetic of familial breast cancer and their practical implications. Eur J Cancer 30: 1383-1390
16. Fariksdottir G, Sigurdsson A, Jonasson JG, Agnarsson BA, Sigurdsson H, Gudmundsson J, Bergthorsson JT, Barkardottir RB, Egilsson V and Ingvarsson S (1995) Loss of heterozygosity on chromosomes 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions. Int J Cancer 64: 378-382
17. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumourigenesis. Cell 62: 759-767
18. Futreal PA, Liu Q, Shattuck Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver Feldhaus J, Ding W, Gholami Z, Söderquist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A and Wiseman R (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122
19. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L and Robertson M (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600
20. Guan XY, Xu J, Anzick SL, Zhang H, Trent JM and Meltzer PS (1996) Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within an amplified region at 20q11 q13.2 in breast cancer. Cancer Res 56: 3446-3450
21. Hunter T and Pines J (1994) Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79(4): 573-582
22. Isola J, DeVries S, Chu I, Ghazvini S and Waldman F (1994) Analysis of changes in DNA sequence copy number comparative genomic hybridization in archival paraffin-embedded tumour samples. Am J Pathol 145: 1301-1308
23. Isola JJ, Kallioniemi OP, Chu LW, Fuqua SAW, Hilsenbeck SG, Osborne CK and Waldman FM (1995). Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 147: 905-911
24. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 258: 818-821
25. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW and Waldman FM (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci 91: 2156-2160
26. Kelley MJ, Nakagawa K, Steinberg SM, Mulshine JL, Kamb A and Johnson BE (1995). Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J Natl Cancer Inst 87: 756-761
27. Kerangueven F, Allione F, Noguchi T, Adelaide J, Sobol H, Jacquemier J and Birnbaum D (1995) Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumours. Genes Chromosome Cancer 13: 291-294
28. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Aschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I and Nakamura Y (1991) Identification of FAP locus genes from chromosome 5q21. Science 253(5020): 661-665
29. Koreth J, Bakkenist CJ and McGee J (1997) Allelic deletions at chromosome 11q22 q23.1 and 11q25 qterm are frequent in sporadic breast but not colorectal cancer. Oncogene 14: 431-437
30. Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP and Isola J (1997) Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57: 1597-1604
31. Laake K, Odegard A, Andersen TI, Bukholm IK, Karesen R, Nesland JM, Ottestad L, Shiloh Y and Borresen-Dale AL (1997) Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosom Cancer 18: 175-180
32. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR and Futreal PA (1996) BRCA2 mutations in primary breast and ovarian cancers. Nature Genet 13: 238-240
33. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A and Dejean A (1997) Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosome Cancer 18(1): 59-65
34. Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B and Dutrillaux B (1995) Identification of amplified DNA sequences in breast cancer and their organization within homogenously staining regions. Genes Chromosom Cancer 14(3): 155-163
35. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N and Waldman FM (1997a) Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 74: 513-517
36. Nishizaki T, DeVries S, Chew K, Goodson WH 3rd, Ljung BM, Thor A and Waldman FM (1997b) Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosome Cancer 19: 267-272
37. Norton AJ, Jordan S and Yeomans P (1994) Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173: 371-379
38. Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T and Dietel M (1997a) Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 75: 79-86
39. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M and Ried T (1997b) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57: 2331-2335
40. Polascik TJ, Cairns P, Epstein JL, Fuzesi L, Ro JY, Marshall FF, Sidransky D and Schoenberg M (1996) Distal nephron renal tumours: microsatellite allelotype. Cancer Res 56(8): 1892-1895
41. Ried T, Just KE, Holtsgreve-Grez H, du Manoir S, Speicher MR, Schröck E, Latham C, Blegen H, Zetterberg A, Cremer T and Auer G (1995) Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumours reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 55: 5415-5423
42. Rimm DL, Sinard JH and Morrow JS (1995) Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab Invest 72: 506-512
43. Roth K, Wolf G, Dietel M and Petersen I (1997) Image analysis for comparative genomic hybridization (CGH) based on a karyotyping program for Windows. Anal Quant Cytol Histol 19: 461-474
44. Sakata K, Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Tevashima M, Saito K and Satodate R (1997) Commonly deleted regions on the long arm of chromosome 21 in differentiated adenocarcinoma of the stomach. Genes Chrom Cancer 18: 318-321
45. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G and Nakamura Y (1990) Allelotype of breast cancer: cumulative allele losses promote tumour progression in primary breast cancer. Cancer Res 50: 7814-7819
46. Schmutzler RK, Fimmers R, Bierhoff E, Lohmar B, Homann A, Speiser P, Kubista E, Jaeger K, Krebs D, Zeillinger R, Wiestler OD and Deimling AV (1996) Association of allelic losses on human chromosomal arms 11Q and 16Q in sporadic breast cancer. Int J Cancer 69(4): 307-311
47. Schwendel A, Langreck H, Reichel M, Schröck E, Ried T, Dietel M and Petersen I (1997) Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer 74: 86-93
48. Solinas-Toldo S, Wallrapp C, Muller-Pillasch F, Bentz M, Gress T and Lichter P (1996) Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56(16): 3803-3807
49. Spandidos D, Karaiossifidi H, Malliri A, Linardopoulos S, Vassilaros S, Tsikkinis A and Field JK (1992) Expression of Ras Rb1 and p53 in human breast cancer. Anticancer Res 12: 81-90
50. Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Terashima M, Eda Y and Satodate R (1996) Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol 180: 371-377
51. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo WL, Waldman FM, Isola JJ, Gray JW and Kallioniemi OP (1994) Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 54: 4257-4260
52. Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg A and Kallioniemi OP (1997) Distinct somatic genetic changes associated with tumour progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 57: 1222-1227
53. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yokota J, Yoshida T, Sakomoto H, Terada M and Sugimura T (1989) Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res 49: 3104-3108
54. Tsuda H, Callen DF, Fukutomi T, Nakamura Y and Hirohashi S (1994) Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res 54: 513-517
55. Wasmuth JJ, Park C and Ferrell RE (1989) Report of the committee on the genetic constitution of chromosome 5. Cytogenet Cell Genet 51: 137-148
56. Winquist R, Hampton GM, Mannermaa A, Blanco G, Alavaikko H, Kiviniemi H, Taskinen PJ, Evans FA, Newsham I and Cavenee WK (1995) Loss of heterozygosity for chromosome 11 in primary human breast tumours is associated with poor survival after metastasis. Cancer Res 55: 2660-2664
57. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor E, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P and Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792